ALK Genomic Aberrations in NSCLC and Clinical Implications

被引：0
|
作者：
Hirsch, F. R. [1 ]
机构：
[1] Mt Sinai, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Crizotinib; Ceritinib; Alectinib; Brigatinib; Lorlatinib; CHEMOTHERAPY; CRIZOTINIB;
D O I：
10.1016/j.jtho.2019.09.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
I.17
引用
收藏
页码：S1163 / S1164
页数：3
相关论文
共 50 条
  • [1] Analysis of the Genomic Landscape in ALK plus NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes
    du Tertre, Mathilde Couetoux
    Marques, Maud
    Tremblay, Lise
    Bouchard, Nicole
    Diaconescu, Razvan
    Blais, Normand
    Couture, Christian
    Pelsser, Vincent
    Wang, Hangjun
    Higenell, Valerie
    Izzi, Luisa
    Gambaro, Karen
    Hoffert, Cyrla
    Srivastava, Archana
    Spatz, Alan
    Rousseau, Caroline
    McNamara, Suzan
    Cohen, Victor
    Batist, Gerald
    Agulnik, Jason
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (09) : 1628 - 1636
  • [2] Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC
    Friedlaender, Alex
    Banna, Giuseppe
    Patel, Sandip
    Addeo, Alfredo
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (10)
  • [3] Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC
    Alex Friedlaender
    Giuseppe Banna
    Sandip Patel
    Alfredo Addeo
    Current Treatment Options in Oncology, 2019, 20
  • [4] Clinical and biologic implications of recurrent genomic aberrations in myeloma
    Fonseca, R
    Blood, E
    Rue, M
    Harrington, D
    Oken, MM
    Kyle, RA
    Dewald, GW
    Van Ness, B
    Van Wier, SA
    Henderson, KJ
    Bailey, RJ
    Greipp, PR
    BLOOD, 2003, 101 (11) : 4569 - 4575
  • [5] Concurrent Genomic Alterations on Clinical Outcomes in Patients With Alk-rearranged NSCLC
    Bornstein-Quevedo, Leticia
    Duenas-Gonzalez, Alfonso
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (02) : e19 - e19
  • [6] Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK Rearranged NSCLC
    Lara-Mejia, Luis
    Cardona, Andres F.
    Mas, Luis
    Martin, Claudio
    Samtani, Suraj
    Corrales, Luis
    Cruz-Rico, Graciela
    Remon, Jordi
    Galvez-Nino, Marco
    Ruiz, Rossana
    Rios-Garcia, Eduardo
    Tejada, Fernanda
    Lozano-Vazquez, Natalia
    Rosell, Rafael
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (01) : 119 - 129
  • [7] Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
    Seker-Cin, Huriye
    Tay, Timothy Kwang Yong
    Kazdal, Daniel
    Kluck, Klaus
    Ball, Markus
    Neumann, Olaf
    Winter, Hauke
    Herth, Felix
    Heussel, Claus-Peter
    Savai, Rajkumar
    Schirmacher, Peter
    Thomas, Michael
    Budczies, Jan
    Allgaeuer, Michael
    Christopoulos, Petros
    Stenzinger, Albrecht
    Volckmar, Anna-Lena
    LUNG CANCER, 2023, 184
  • [8] Genomic aberrations of ALK in head and neck squamous cell carcinoma
    Wang, Lan
    Liu, Yuchen
    Piao, Wenying
    Poon, Peony Hiu Yan
    Yeung, Chun Kit
    Chan, Amy Bik Wan
    Lau, Chin Wang
    Su, Yuxiong
    Chan, Jason Ying Kuen
    Lui, Vivian Wai Yan
    CANCER RESEARCH, 2019, 79 (13)
  • [9] ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC
    Berghoff, Anna Sophie
    Birner, Peter
    Streubel, Berthold
    Kenner, Lukas
    Preusser, Matthias
    APMIS, 2014, 122 (09) : 867 - 872
  • [10] Genomic profiling of gene aberrations in 323 Chinese NSCLC patients
    Liu, Y.
    Xu, C.
    Wang, W-X.
    Song, Z.
    Zhu, Y.
    Guan, Y.
    Chen, R.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S12 - S13
12345